U.S. Markets open in 8 hrs 27 mins

CTI BioPharma Corp. (CTIC)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
3.35+0.23 (+7.37%)
At close: 4:00PM EDT
People also watch
HEBAGENXOMAKERXGERN
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue57,40516,11660,077
Cost of Revenue1,3771,940895
Gross Profit56,02814,17659,182
Operating Expenses
Research Development64,96176,62764,596
Selling General and Administrative40,22954,21558,960
Non Recurring--21,859
Others---
Total Operating Expenses---
Operating Income or Loss-49,162-116,666-86,233
Income from Continuing Operations
Total Other Income/Expenses Net-1,177-1,993-6,049
Earnings Before Interest and Taxes-50,339-118,659-92,282
Interest Expense2,6142,1041,947
Income Before Tax-52,953-120,763-94,229
Income Tax Expense---
Minority Interest-5,562-4,618-3,277
Net Income From Continuing Ops-52,009-119,422-93,367
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-52,009-119,422-93,367
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-52,009-122,622-95,992